Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," “stabilization,” “confident,” “preliminary,” “initial,” and similar expressions and variations or negatives of these words. Capitalized terms used in this section but not defined below have the meanings assigned in the Notes to the Consolidated Financial StatementsAll statements, other than statements of this Quarterly Report on Form 10-Q.historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance.

Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) the possibility that the Company may fail to realize the anticipated benefits of the $5$1 billion share repurchase program announced on November 8, 2022February 6, 2024 and that the program may be suspended, discontinued or not completed prior to its termination on June 30, 2024;2025; (ii) abilityrisks and uncertainties related to achieve anticipated tax treatments in connectionthe settlement agreement concerning PFAS liabilities reached June 2023 with mergers, acquisitions, divestitures,plaintiff water utilities by Chemours, Corteva, EIDP and other portfolio changes and the impact of changes in relevant tax and other laws;DuPont; (iii) indemnification of certain legacy liabilities; (iv) risks and costs related to each of the parties respective performance under and the impact of the arrangement to share future eligible PFAS costs by and between DuPont, Corteva and Chemours;Chemours, including the outcome of any pending or future litigation related to PFAS or PFOA, including personal injury claims and natural resource damages claims; the extent and cost of ongoing remediation obligations and potential future remediation obligations; changes in laws and regulations applicable to PFAS chemicals; (iv) ability to achieve anticipated tax treatments in connection with completed and future, if any, divestitures, mergers, acquisitions and other portfolio changes actions and impact of changes in relevant tax and other laws; (v) indemnification of certain legacy liabilities; (vi) failure to timely close on anticipated terms (or at all), realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with completed and future, if any, divestitures, mergers, acquisitions, divestitures and other portfolio changes, including the acquisition of Spectrum; (vi)management, productivity and infrastructure actions; (vii) risks and uncertainties, including increased costs and the ability to obtain raw materials related to operational and supply chain impacts or disruptions, which may resultmeet customer needs from, among other events, pandemics and responsive actions,actions; timing and recovery from demand declinedeclines in consumer-facing markets, including in China,China; adverse changes in worldwide economic, political, regulatory, international trade, geopolitical, capital markets and geo-politicalother external conditions; and other factors beyond the Company's control, including inflation, recession, military conflicts, natural and other disasters or weather related events; (vii)events, that impact the operations of the Company, its customers and/or suppliers; (viii) ability to offset increases in cost of inputs, including raw materials, energy and logistics; (viii)(ix) risks associated with demand and market conditions in the semiconductor industry and associated end markets, including from continuing or expanding trade disputes or restrictions, including on exports to China of U.S.-regulated products and technology impacting the semiconductor business; (ix)technology; (x) risks, including ability to achieve, and costs associated with DuPont’s sustainability strategy including the actual conduct of the company’s activities and results thereof, and the development, implementation, achievement or continuation of any goal, program, policy or initiative discussed or expected; and (x)(xi) other risks to DuPont's business operations;and operations, including the risk of impairment; each as further discussed in DuPont’s most recent annual report and subsequent current and periodic reports filed with the U.S. Securities and Exchange Commission. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

ITEM 1. FINANCIAL STATEMENTS

In these notes, the terms "DuPont" or "Company" used herein mean DuPont de Nemours, Inc. and its consolidated subsidiaries. The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the interim statements reflect all adjustments (including normal recurring accruals) which are considered necessary for the fair statement of the results for the periods presented. Results from interim periods should not be considered indicative of results for the full year. These interim Consolidated Financial Statements should also be read in conjunction with the audited Consolidated Financial Statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022,2023, collectively referred to as the "2022"2023 Annual Report." The interim Consolidated Financial Statements include the accounts of the Company and all of its subsidiaries in which a controlling interest is maintained.

The financial positioninterim Consolidated Statements of DuPont asOperations and the interim Consolidated Statements of March 31, 2023 and December 31, 2022, present the businesses to be divested as part of the Delrin® Divestiture, as discontinued operations. The results of operationsCash Flows for the three months ended March 31, 2023, present the financial results and cash flows of Delrin® as discontinued operations. The results of operations for the three months ended March 31, 2022, present the financial results of the M&M Businesses as discontinued operations. The cash flows and comprehensive income of the M&M Businesses haveDelrin® has not been segregated and areis included in the interim Consolidated Statements of Cash Flows and interim Consolidated Statements of Comprehensive Income respectively, for all periods presented. Unless otherwise indicated, the information in the notes to the interim Consolidated Financial Statements refer only to DuPont's continuing operations and do not include discussion of balances or activity of the M&M Businesses. See Note 3 for more information.

NOTE 2 - RECENT ACCOUNTING GUIDANCE

In September 2022, the FASB issued Accounting Standards Update No. 2022-04, "Liabilities-Supplier Finance Programs (Subtopic 405-50)" ("ASU 2022-04") to enhance transparency about the use of supplier finance programs. The new guidance requires that a buyer in a supplier finance program provides additional qualitative and quantitative disclosures about its program including the nature of the program, activity during the period, changes from period to period, and the potential magnitude of the program. The amendments in ASU 2022-04 are effective for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods within those fiscal years, except for the amendment on rollforward information which is effective prospectively for fiscal years beginning after December 15, 2023.

The interim results of operations for the three months ended March 31, 2023, representsrepresent the Delrin® business comparatively, at March 31, 2022, the results of operations are related to both M&M Businesses.unless otherwise indicated. The following table summarizes the interim results of operations of the M&M BusinessesDivestitures which are presented as discontinued operations as summarized below:

The Company recorded incomea gain from discontinued operations, net of tax of $(8)$14 million and $276a loss of $8 million for the three months ended March 31, 20232024 and 2022,2023, respectively.

Discontinued operations activity consists of the following:

Substantially all of DuPont's revenue is derived from product sales. Product sales consist of sales of DuPont's products to supply manufacturers and distributors. DuPont considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year.

The Company disaggregates its revenue from contracts with customers by segment and business or major product line and geographic region, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows.

From time to time, the Company enters into arrangements in which it receives payments from customers based upon contractual billing schedules. The Company records accounts receivables when the right to consideration becomes unconditional. Contract liabilities primarily reflect deferred revenue from advance payment for product that the Company has received from customers. The Company classifies deferred revenue as current or noncurrent based on the timing of when the Company expects to recognize revenue.

Revenue recognized in the first three months of 20232024 and 20222023 from amounts included in contract liabilities at the beginning of the period was insignificant. Current and noncurrent deferred revenue balances in the current and comparative periods were also not material.

The Company records restructuring liabilities that represent nonrecurring charges in connection with simplifying certain organizational structures and operations, including operations related to transformational projects such as divestitures and acquisitions. Charges for restructuring programs and asset related charges, which includesinclude asset impairments, were $39 million and $14 million for the three months ended March 31, 20232024, and $101 million for the three months ended March 31, 2022.2023. These charges were recorded in "Restructuring and asset related charges - net" in the interim Consolidated Statements of Operations. The total liability related to restructuring programs was $60$101 million at March 31, 20232024 and $67$107 million at December 31, 2022,2023, recorded in "Accrued and other current liabilities" in the interim Condensed Consolidated Balance Sheets. Raw Material inventory write-offs associated with restructuring programs are recorded to "Cost of Sales” in the interim Consolidated Statements of Operations. Restructuring activity primarily consists of the following programs:

In October 2022, the Company approved targeted restructuring actions to capture near-term cost reductions and to further simplify certain organizational structures following the M&M Divestitures (the "2022 Restructuring Program"). The Company recorded pre-tax restructuring charges of $71$99 million inception-to-date, consisting of severance and related benefit costs of $68$85 million and asset related charges of $14 million. The Company recorded pre-tax restructuring charges of $3 million.million, to Corporate & Other for the three months ended March 31, 2024.

Total liabilities related to the 2022 Restructuring Program were $53$18 million at March 31, 20232024 and $57$27 million at December 31, 2022,2023, respectively, recognized in "Accrued and other current liabilities" in the interim Condensed Consolidated Balance Sheet. The Company expects the program to be substantially complete by the end of 2023.

Each year the Company files hundreds of tax returns in the various national, state, and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. PositionsThe Company has ongoing federal, state, and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by thelocal tax authorities may be settled or appealed by the Company.authorities. As a result, there is an uncertainty in income taxes recognized in the Company’s financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. The ultimate resolution of such uncertainties is not expected to have a material impact on the Company's interim results of operations.

The Company's effective tax rate fluctuates based on, among other factors, where income is earned and the level of income relative to tax attributes. The effective tax rate on continuing operations for the first quarter of 20232024 was 23.331.5 percent, compared with an effective tax rate of 16.823.3 percent for the first quarter of 2022.2023. The lowerhigher effective tax rate for the first quarter of 2022 principally resulted from2024 was driven by the recognitiongeographic mix of a $94 million impairment chargeearnings offset by the U.S. taxation of foreign operations as well as certain one-time discrete tax expenses, including an equity method investmentinternational statutory tax assessment received for which resulted in a tax benefit of $29 million.the Company is indemnified.

As a result ofEffective from 2024, the M&M Businesses meetingOrganization for Economic Co-operation and Development’s ("OECD") Global Anti-Base Erosion ("GloBE") rules under Pillar Two have been enacted by the held for sale criteriaEuropean Union and other countries in the first quarter of 2022,which the Company recordedoperates. The Company does not expect a net deferredresulting material change to the income tax benefit of $239 millionprovision for the year ended December 31, 2024. However, the Company expects the effective tax rate and cash tax payments could increase in the first quarter of 2022 in connection with certain anticipated internal stock restructurings. These restructurings involved both legal entities within the M&M Businesses and legal entities which remained with DuPont. The aforementioned net deferred tax benefit is included in “Income from discontinued operations, net of tax” in the interim Consolidated Statements of Operations. See Note 3 for additional information on the M&M Divestitures.future years.

The following tables provide earnings per share calculations for the three months ended March 31, 20232024 and 2022:2023: